Rui Jiang

Corporate Secretary presso JINKO SOLAR CO., LTD.

41 anni

Process Industries

Consumer Services

Electronic Technology

Profilo

Rui Jiang currently works at Cali Biosciences Co. Ltd., as Non-Executive Director from 2021 and Jinko Solar Co., Ltd., as Secretary from 2021.
Mr. Jiang also formerly worked at Bloomage Biotechnology Corp.
Ltd., as Board Secretary, Director & Deputy General Manager from 2019 to 2020.
Mr. Jiang received his graduate degree in 2008 from Renmin University of China.

Posizioni attive di Rui Jiang

Società	Posizione	Inizio
JINKO SOLAR CO., LTD.	Corporate Secretary	07/01/2021
Cali Biosciences Co. Ltd. Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China.	Director/Board Member	17/03/2021

Tutte le posizioni attive di Rui Jiang

Precedenti posizioni note di Rui Jiang

Società	Posizione	Fine
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	Director/Board Member	25/12/2020

Vedi nel dettaglio l'esperienza di Rui Jiang

Formazione di Rui Jiang

Renmin University of China

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Rui Jiang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	Process Industries
JINKO SOLAR CO., LTD.	Electronic Technology

Aziende private	1
Cali Biosciences Co. Ltd. Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China.	Health Technology